Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuan-Wei Chen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Biomedical Materials Research. Part A|April 16, 2011
Enhancing blood compatibility of biodegradable polymers by introducing sulfobetaineJun Cao, Yuan-Wei Chen, Xin Wang, et al.
Acta Pharmacologica Sinica|November 2, 2018
Bevacizumab or fibronectin gene editing inhibits the osteoclastogenic effects of fibroblasts derived from human radicular cystsHai-Cheng Wang, Peng Wang, Yuan-Wei Chen, et al.
Macromolecular Bioscience|July 28, 2011
Enhancement of cellular uptake and antitumor efficiencies of micelles with phosphorylcholineSong Tu, Yuan-Wei Chen, Yong-Bin Qiu, et al.
Journal of Biomedical Materials Research. Part A|May 15, 2012
Copolymer nanoparticles composed of sulfobetaine and poly(ε-caprolactone) as novel anticancer drug carriersJun Cao, Ke-Mao Xiu, Kun Zhu, et al.
Biomaterials|September 7, 2005
Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffoldsKai Qiu, Xiao Jun Zhao, Chang Xiu Wan, et al.
ACS Macro Letters|May 24, 2022
Polymeric Nanocubes Spontaneously Formed from Poly(ε-caprolactone)Song Tu, Bei-Lei Wang, Yuan-Wei Chen, et al.
Nephrologie & Therapeutique|January 25, 2022
Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studiesJun-Yong Ou, Yuan-Wei Chen, Tian-Long Li, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Materials Research. Part A|April 16, 2011
Enhancing blood compatibility of biodegradable polymers by introducing sulfobetaineJun Cao, Yuan-Wei Chen, Xin Wang, et al.
Acta Pharmacologica Sinica|November 2, 2018
Bevacizumab or fibronectin gene editing inhibits the osteoclastogenic effects of fibroblasts derived from human radicular cystsHai-Cheng Wang, Peng Wang, Yuan-Wei Chen, et al.
Macromolecular Bioscience|July 28, 2011
Enhancement of cellular uptake and antitumor efficiencies of micelles with phosphorylcholineSong Tu, Yuan-Wei Chen, Yong-Bin Qiu, et al.
Journal of Biomedical Materials Research. Part A|May 15, 2012
Copolymer nanoparticles composed of sulfobetaine and poly(ε-caprolactone) as novel anticancer drug carriersJun Cao, Ke-Mao Xiu, Kun Zhu, et al.
Biomaterials|September 7, 2005
Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffoldsKai Qiu, Xiao Jun Zhao, Chang Xiu Wan, et al.
ACS Macro Letters|May 24, 2022
Polymeric Nanocubes Spontaneously Formed from Poly(ε-caprolactone)Song Tu, Bei-Lei Wang, Yuan-Wei Chen, et al.
Nephrologie & Therapeutique|January 25, 2022
Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studiesJun-Yong Ou, Yuan-Wei Chen, Tian-Long Li, et al.
Pageof 1